TNXP
Tonix Pharmaceuticals Holding Corp.
NASDAQ · USHealthcareBiotechnology
$10.98-11.67%
Price as of Jul 20, 2026
TNXP valuation
Tonix Pharmaceuticals Holding Corp. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.22x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.77x
- Price / sales
- 9.97x
- Price / cash flow
- -1.39x
Enterprise value
- Enterprise value
- -$9.2M
- EV / sales
- -0.52x
- EV / EBITDA
- 0.06x
- EV / EBIT
- 0.06x
- Market cap
- $175.0M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.